title: Treatment of primary melanoma of the lung monitored by 5-S-cysteinyldopa levels.
abstract: Malignant melanoma originating outside the skin is very rare, whereas primary malignant melanoma of the lung is extremely rare. 5-S-Cysteinyldopa (5-S-CD), a melanin metabolite, has been reported to be a prognostic marker for cutaneous malignant melanoma. This is the first report in the English language literature dealing with primary malignant melanoma of the lung using serum 5-S-Cysteinyldopa levels to monitor the effects of surgery and chemotherapy.
authors.affiliation: Division of Thoracic Surgery, Respiratory Disease Center, The Tazuke Kofukai Medical, Research Institute Kitano Hospital, Kita-ku, Osaka, Japan.
authors.forename: Kei
authors.initials: K
authors.lastname: Shikuma
authors.forename: Mitsugu
authors.initials: M
authors.lastname: Omasa
authors.forename: Yojiro
authors.initials: Y
authors.lastname: Yutaka
authors.forename: Masato
authors.initials: M
authors.lastname: Okuda
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Taki